Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GLPG

Galapagos (GLPG)

Galapagos
Date:
Sort by:
 Showing the most relevant articles for your search:EU:GLPG
DateTimeSourceHeadlineSymbolCompany
03/17/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
02/20/20204:01PMGlobeNewswire Inc.Transformational year for GalapagosEU:GLPGGalapagos
02/20/20204:01PMGlobeNewswire Inc.Transformational year for GalapagosEU:GLPGGalapagos
01/29/20202:00AMGlobeNewswire Inc.Orphan Drug Designation for GLPG1690 in systemic sclerosisEU:GLPGGalapagos
01/29/20202:00AMGlobeNewswire Inc.Orphan Drug Designation for GLPG1690 in systemic sclerosisEU:GLPGGalapagos
01/23/20204:01PMGlobeNewswire Inc.Galapagos appoints Michele Manto as Chief Commercial OfficerEU:GLPGGalapagos
01/23/20204:01PMGlobeNewswire Inc.Galapagos appoints Michele Manto as Chief Commercial OfficerEU:GLPGGalapagos
01/15/20201:30AMGlobeNewswire Inc.Fibrocor and Galapagos sign expanded collaboration in fibrosisEU:GLPGGalapagos
01/13/20201:30AMGlobeNewswire Inc.Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosisEU:GLPGGalapagos
01/13/20201:30AMGlobeNewswire Inc.Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosisEU:GLPGGalapagos
01/09/20204:01PMGlobeNewswire Inc.Galapagos to present at 38th Annual J.P. Morgan Healthcare ConferenceEU:GLPGGalapagos
01/09/20204:01PMGlobeNewswire Inc.Galapagos to present at 38th Annual J.P. Morgan Healthcare ConferenceEU:GLPGGalapagos
01/09/20204:01PMGlobeNewswire Inc.Gilead holds 25.84% of Galapagos sharesEU:GLPGGalapagos
01/09/20204:01PMGlobeNewswire Inc.Gilead holds 25.84% of Galapagos sharesEU:GLPGGalapagos
12/19/20194:30PMGlobeNewswire Inc.Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid ...EU:GLPGGalapagos
12/19/20194:30PMGlobeNewswire Inc.Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid ...EU:GLPGGalapagos
12/05/20194:01PMGlobeNewswire Inc.Galapagos completes recruitment of NOVESA trial in systemic sclerosisEU:GLPGGalapagos
12/05/20194:01PMGlobeNewswire Inc.Galapagos completes recruitment of NOVESA trial in systemic sclerosisEU:GLPGGalapagos
11/25/20194:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
11/25/20194:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
11/18/20194:01PMGlobeNewswire Inc.Galapagos receives transparency notification from Wellington Management Group LLPEU:GLPGGalapagos
11/18/20194:01PMGlobeNewswire Inc.Galapagos receives transparency notification from Wellington Management Group LLPEU:GLPGGalapagos
11/13/20194:01PMGlobeNewswire Inc.Transparency notification – Gilead holds 25.10% of Galapagos sharesEU:GLPGGalapagos
11/13/20194:01PMGlobeNewswire Inc.Transparency notification – Gilead holds 25.10% of Galapagos sharesEU:GLPGGalapagos
11/09/20194:30PMGlobeNewswire Inc.NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILEEU:GLPGGalapagos
11/09/20194:30PMGlobeNewswire Inc.NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILEEU:GLPGGalapagos
11/06/20194:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercise by GileadEU:GLPGGalapagos
11/06/20194:01PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercise by GileadEU:GLPGGalapagos
11/01/20194:01PMGlobeNewswire Inc.Gilead delivers exercise notice to Galapagos for Initial Warrant A to increase ownership to 25.1%EU:GLPGGalapagos
11/01/20194:01PMGlobeNewswire Inc.Gilead delivers exercise notice to Galapagos for Initial Warrant A to increase ownership to 25.1%EU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG